Your browser is no longer supported. Please, upgrade your browser.
ADIL Adial Pharmaceuticals, Inc. daily Stock Chart
Adial Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.79 Insider Own6.20% Shs Outstand10.50M Perf Week15.53%
Market Cap29.35M Forward P/E- EPS next Y-0.58 Insider Trans4.78% Shs Float8.39M Perf Month25.68%
Income-8.20M PEG- EPS next Q-0.18 Inst Own10.00% Short Float0.97% Perf Quarter39.33%
Sales- P/S- EPS this Y64.30% Inst Trans82.43% Short Ratio0.09 Perf Half Y4.49%
Book/sh0.53 P/B3.51 EPS next Y- ROA-96.80% Target Price- Perf Year10.71%
Cash/sh0.32 P/C5.87 EPS next 5Y- ROE-104.00% 52W Range1.00 - 3.17 Perf YTD-22.82%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-41.32% Beta-
Dividend %- Quick Ratio15.20 Sales past 5Y- Gross Margin- 52W Low86.00% ATR0.23
Employees3 Current Ratio15.20 Sales Q/Q- Oper. Margin- RSI (14)62.98 Volatility23.19% 13.81%
OptionableNo Debt/Eq0.00 EPS Q/Q33.30% Profit Margin- Rel Volume3.94 Prev Close1.92
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume893.13K Price1.86
Recom2.00 SMA2021.83% SMA5022.47% SMA20015.80% Volume3,519,901 Change-3.12%
Oct-30-18Initiated Maxim Group Buy $5
Oct-11-18Initiated Dawson James Buy
Aug-06-20 09:30AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-22-20 09:45AM  
Jul-06-20 08:15AM  
Jun-25-20 09:30AM  
Jun-17-20 09:55AM  
Jun-15-20 09:30AM  
Jun-11-20 11:35AM  
Jun-10-20 10:06AM  
Jun-09-20 09:15AM  
Jun-08-20 09:30AM  
May-28-20 09:30AM  
May-04-20 10:15AM  
Apr-23-20 08:45AM  
Apr-16-20 10:17AM  
Apr-15-20 09:45AM  
Apr-09-20 09:30AM  
Mar-29-20 08:19AM  
Mar-26-20 09:15AM  
Mar-17-20 09:30AM  
Feb-19-20 09:37AM  
Feb-14-20 09:15AM  
Feb-06-20 12:30PM  
Jan-09-20 09:15AM  
Dec-30-19 05:36AM  
Dec-19-19 09:30AM  
Dec-16-19 09:00AM  
Dec-13-19 09:30AM  
Oct-29-19 08:30AM  
Oct-17-19 10:30AM  
Oct-07-19 09:26AM  
Oct-01-19 08:30AM  
Sep-27-19 11:52AM  
Sep-25-19 09:50AM  
Sep-11-19 09:15AM  
Sep-07-19 09:30AM  
Aug-06-19 04:30PM  
Jul-29-19 03:01PM  
Jun-19-19 09:00AM  
Jun-13-19 09:35AM  
Jun-06-19 09:00AM  
May-07-19 09:00AM  
Apr-30-19 09:00AM  
Apr-29-19 11:56AM  
Apr-22-19 09:00AM  
Apr-11-19 09:00AM  
Apr-04-19 09:00AM  
Apr-03-19 09:00AM  
Mar-26-19 09:00AM  
Mar-25-19 08:00AM  
Feb-28-19 03:02PM  
Feb-26-19 08:00AM  
Feb-21-19 01:35PM  
Feb-20-19 09:00AM  
Feb-15-19 08:30AM  
Feb-12-19 09:33AM  
Feb-07-19 09:15AM  
Feb-01-19 09:20AM  
Jan-24-19 08:30AM  
Jan-23-19 01:57PM  
Jan-17-19 09:00AM  
Jan-15-19 09:05AM  
Jan-10-19 08:00AM  
Dec-27-18 10:25AM  
Dec-26-18 04:18PM  
Dec-24-18 08:00AM  
Dec-20-18 06:50AM  
Dec-19-18 09:00AM  
Dec-14-18 06:55AM  
Dec-13-18 12:49PM  
Dec-10-18 08:00AM  
Dec-04-18 06:45AM  
Nov-29-18 10:10AM  
Nov-21-18 08:00AM  
Nov-19-18 08:00AM  
Nov-14-18 08:00AM  
Nov-08-18 09:20AM  
Oct-23-18 08:00AM  
Sep-26-18 02:15PM  
Sep-18-18 07:30AM  
Sep-12-18 09:00AM  
Sep-04-18 08:00AM  
Aug-27-18 09:00AM  
Aug-15-18 08:00AM  
Aug-02-18 05:31PM  
Jul-31-18 04:05PM  
Jul-27-18 07:00AM  
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in Charlottesville, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Newman James W. Jr.DirectorMar 27Buy1.3414,64419,66914,644Mar 30 09:23 AM
Newman James W. Jr.DirectorMar 27Buy1.425,0007,10015,000Mar 30 09:23 AM
Stilley William B. IIIChief Executive OfficerMar 26Buy1.4712,65218,598715,937Mar 27 06:03 AM
Stilley William B. IIIChief Executive OfficerMar 25Buy1.1312,34813,953703,285Mar 27 06:03 AM
Johnson Bankole A.Chief Medical OfficerDec 12Sale1.00150,000150,000698,336Dec 13 09:00 PM